ibi321
mAbexperimentalBi-specific
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2021 (NCT04911881)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05172856 | Phase 1 | Mar 1, 2022 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT04911894 | Phase 1 | Jul 16, 2021 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT04911881 | Phase 1 | Jul 1, 2021 | Innovent Biologics (Suzhou) Co. Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | For profit | 3 | 3 | 1 | 2021 |
1 organizations
Page 1 / 1